Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes

Sulfonylurea (SU) and dipeptidyl peptidase-4 (DPP-4) inhibitors are most common secondary agents that are added to metformin monotherapy. Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice and real-world data could help appropr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Clin Pharmacol
Hlavní autoři: Lee, Suhrin, Lee, SeungHwan, Jang, In-Jin, Yu, Kyung-Sang, Rhee, Su-jin
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Society for Clinical Pharmacology and Therapeutics 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781806/
https://ncbi.nlm.nih.gov/pubmed/33425803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e21
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky